Rituximab usage in children: a double edged sword
SP Yadav, V Chinnabhandar - Indian Pediatr, 2012 - indianpediatrics.net
We read the recent article on Rituximab by Borker, et al. with great interest [1]. This letter
reports our experience with Rituximab in children for various indications. A brief tabulation of …
reports our experience with Rituximab in children for various indications. A brief tabulation of …
A retrospective study on infusion-related reactions to rituximab in a heterogeneous pediatric population
C Legeay, H Bittencourt, E Haddad… - The Journal of …, 2017 - meridian.allenpress.com
OBJECTIVES To assess risks and outcomes of infusion-related reactions to rituximab in a
heterogeneous pediatric population. METHODS All patients who received rituximab …
heterogeneous pediatric population. METHODS All patients who received rituximab …
Rapid infusion of rituximab in a heterogenous pediatric population: safety and feasibility
C Legeay, L Spiesser-Robelet… - Journal of Pediatric …, 2016 - journals.lww.com
LWWUS_MPH_JPHO-15-334 81..85 Page 1 Rapid Infusion of Rituximab in a Heterogenous
Pediatric Population: Safety and Feasibility To the Editor: Many oncologic and immunologic …
Pediatric Population: Safety and Feasibility To the Editor: Many oncologic and immunologic …
Rapid infusion of rituximab is well tolerated in children with hematologic, oncologic, and rheumatologic disorders
MB Bernhardt, MM De Guzman, A Grimes… - Pediatric Blood & …, 2018 - Wiley Online Library
Traditional administration of rituximab requires careful titration and may involve many hours
to minimize the risk of reactions. The objective of this study was to evaluate the safety of …
to minimize the risk of reactions. The objective of this study was to evaluate the safety of …
Available evidence and outcome of off-label use of rituximab in clinical practice
Purpose To analyze the therapeutic indications for off-label use of rituximab, the available
evidence for its use, the outcomes, and the cost. Methods This was a retrospective analysis …
evidence for its use, the outcomes, and the cost. Methods This was a retrospective analysis …
Association of rituximab use with adverse events in children, adolescents, and young adults
CL McAtee, J Lubega, K Underbrink, K Curry… - JAMA Network …, 2021 - jamanetwork.com
Importance Rituximab is among the most frequently used immunotherapies in pediatrics.
Few studies have reported long-term adverse events associated with its use for children …
Few studies have reported long-term adverse events associated with its use for children …
Treatment with rituximab in benign and malignant hematologic disorders in children
LB Giulino, JB Bussel, EJ Neufeld - The Journal of pediatrics, 2007 - jpeds.com
Monoclonal antibodies have had a major impact on the diagnosis and treatment of many
disorders. First discovered in the 1980s, the original monoclonal antibodies were composed …
disorders. First discovered in the 1980s, the original monoclonal antibodies were composed …
Rituximab
A Borker, N Choudhary - Indian Pediatrics, 2011 - Springer
Rituximab is a chimeric mouse-human monoclonal antibody against the CD 20 antigen on
the surface of B lymphocytes. It binds to CD20 and causes B cell death by antibody …
the surface of B lymphocytes. It binds to CD20 and causes B cell death by antibody …
Safety of rituximab in children with auto-immune diseases
B Bader-Meunier, P Quartier, C Wouters - Pediatric Rheumatology, 2008 - Springer
Safety of rituximab in children with auto-immune diseases | Pediatric Rheumatology Skip to main
content SpringerLink Account Menu Find a journal Publish with us Track your research Search …
content SpringerLink Account Menu Find a journal Publish with us Track your research Search …